ProMetic Life Sciences Company Profile (TSE:PLI)

About ProMetic Life Sciences

ProMetic Life Sciences logoPrometic Life Sciences Inc (ProMetic) is a Canada-based biopharmaceutical company. The Company has two segments: Small Molecule Therapeutics and Protein Technology. The Company offers its technology platform for large-scale drug purification of biologics, drug development, proteomics and the elimination of pathogens to various industries, and uses its own affinity technology that provides for extraction and purification of therapeutic proteins from human plasma in order to develop therapeutics and orphan drugs. ProMetic is also developing its own small molecule therapeutic products targeting unmet medical needs in the field of fibrosis, autoimmune disease/inflammation and cancer. It has research and development facilities in the United Kingdom, the United States and Canada; manufacturing facilities in the Isle of Man and Canada, and business development activities in the United States, Europe and Asia.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: TSE
  • Symbol: PLI
  • CUSIP:
Key Metrics:
  • Previous Close: $2.38
  • 50 Day Moving Average: $2.22
  • 200 Day Moving Average: $2.54
  • 52-Week Range: C$620,562,000.00 - C$1.47
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $1.40B
  • Outstanding Shares: 620,562,000
Additional Links:

Analyst Ratings

Consensus Ratings for ProMetic Life Sciences (TSE:PLI) (?)
Ratings Breakdown: 2 Hold Ratings, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: C$4.57

Analysts' Ratings History for ProMetic Life Sciences (TSE:PLI)
Show:
DateFirmActionRatingPrice TargetDetails
2/23/2017ScotiabankReiterated RatingOutperformC$5.00View Rating Details
2/23/2017Royal Bank of CanadaReiterated RatingOutperformView Rating Details
11/23/2016TD SecuritiesReiterated RatingSpeculative BuyC$4.50View Rating Details
11/18/2016Canaccord GenuityBoost Price TargetBuyC$4.50 -> C$4.75View Rating Details
10/13/2016Bloom BurtonReiterated RatingHoldView Rating Details
8/25/2016CIBCLower Price TargetC$5.00 -> C$4.85View Rating Details
5/26/2016National Bank FinancialReiterated RatingOutperformC$4.90View Rating Details
3/28/2016Paradigm CapitalBoost Price TargetBuyC$2.90 -> C$3.30View Rating Details
1/29/2016Panmure GordonBoost Price TargetBuyC$6.70View Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for ProMetic Life Sciences (TSE:PLI)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for ProMetic Life Sciences (TSE:PLI)
Current Year EPS Consensus Estimate: $-0.13 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.03)($0.03)($0.03)
Q2 20161($0.03)($0.03)($0.03)
Q3 20162($0.03)($0.03)($0.03)
Q4 20161($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for ProMetic Life Sciences (TSE:PLI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ProMetic Life Sciences (TSE:PLI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/6/2017Bruce WendelDirectorBuy1,210C$1.66C$2,008.60
10/7/2016Simon Geoffrey BestDirectorBuy2,750C$2.93C$8,057.50
4/6/2016Bruce PritchardInsiderBuy8,800C$3.19C$28,050.88
4/5/2016Bruce WendelDirectorBuy35,200C$2.45C$86,387.84
1/21/2016Raymond Manuel HakimDirectorBuy10,000C$2.77C$27,700.00
1/20/2016Pierre LaurinDirectorBuy2,000C$2.62C$5,240.00
1/19/2016Gregory WeaverInsiderBuy25,000C$2.78C$69,500.00
1/12/2016Louise M�NardDirectorBuy1,867C$2.94C$5,488.98
12/31/2015Kurt Stefan Victor ClulowDirectorBuy273,800C$3.42C$937,737.62
12/29/2015Kurt Stefan Victor ClulowDirectorBuy232,700C$3.22C$749,875.75
12/21/2015Kurt Stefan Victor ClulowDirectorBuy439,500C$3.16C$1,388,160.75
12/4/2015Gregory WeaverInsiderBuy5,000C$2.14C$10,706.50
12/3/2015Gregory WeaverInsiderBuy5,000C$2.24C$11,184.00
12/3/2015Pierre LaurinDirectorSell259,125C$2.99C$774,913.31
11/17/2015Jonathan BoothInsiderBuy25,000C$2.21C$55,225.00
9/30/2015Kurt Stefan Victor ClulowDirectorBuy50,000C$1.43C$71,500.00
9/29/2015Kurt Stefan Victor ClulowDirectorBuy153,400C$1.42C$217,889.36
9/25/2015Raymond Manuel HakimDirectorBuy15,000C$1.69C$25,399.50
9/15/2015Andrew Trevor BishopDirectorBuy10,000C$1.81C$18,100.00
9/8/2015Simon Geoffrey BestDirectorBuy30,000C$1.95C$58,464.00
8/24/2015Nancy Orr-GaucherDirectorBuy2,800C$1.75C$4,900.00
8/21/2015Pierre LaurinDirectorBuy2,400C$1.83C$4,392.00
7/16/2015Simon Geoffrey BestDirectorBuy60,000C$2.43C$145,782.00
7/15/2015Patrick SartoreInsiderSell122,736C$2.30C$282,722.38
7/15/2015Steven J BurtonDirectorSell49,842C$2.30C$114,811.05
7/2/2015Kurt Stefan Victor ClulowDirectorBuy229,900C$2.32C$533,184.08
6/30/2015Kurt Stefan Victor ClulowDirectorBuy770,100C$2.26C$1,742,736.30
6/29/2015Kurt Stefan Victor ClulowDirectorBuy114,750C$2.10C$240,435.68
6/26/2015Kurt Stefan Victor ClulowDirectorBuy885,250C$2.12C$1,879,208.70
6/16/2015Patrick SartoreInsiderBuy2,300C$2.24C$5,152.00
6/12/2015Patrick SartoreInsiderBuy4,000C$2.28C$9,122.00
6/11/2015Louise M�NardDirectorBuy10,000C$2.35C$23,500.00
6/5/2015Raymond Manuel HakimDirectorBuy50,000C$2.45C$122,495.00
6/4/2015Paul MesburisDirectorSell115,593C$2.40C$277,423.20
5/22/2015Nancy Orr-GaucherDirectorSell9,787C$2.47C$24,173.89
4/9/2015Nancy Orr-GaucherDirectorSell9,657C$2.72C$26,267.04
4/7/2015Bruce PritchardInsiderBuy10,200C$2.74C$27,943.92
2/6/2015John Edward MoranDirectorBuy64,500C$1.51C$97,395.00
1/12/2015Patrick SartoreInsiderSell279,656C$1.87C$523,348.24
1/12/2015Pierre LaurinDirectorSell956,264C$1.87C$1,789,552.45
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ProMetic Life Sciences (TSE:PLI)
DateHeadline
News IconTicker Watch: Technical Views on Shares of Prometic Life Sciences Inc (PLI.TO) - Midway Monitor (TSE:PLI)
midwaymonitor.com - February 24 at 8:31 AM
News IconEquity Focus: Looking at Shares of ProMetic Life Sciences Inc. (TSX:PLI) - Piedmont Register (TSE:PLI)
piedmontregister.com - February 22 at 7:23 PM
investors.com logoProMetic confident IPF drug will outperform current treatments after trial - Proactive Investors USA & Canada (TSE:PLI)
www.proactiveinvestors.com - February 22 at 7:23 PM
reuters.com logoBRIEF-Prometic says PBI-4050 shows encouraging efficacy in IPF study (TSE:PLI)
www.reuters.com - February 22 at 9:19 AM
proactiveinvestors.co.uk logoProMetic confident IPF drug will outperform current treatments after trial (TSE:PLI)
www.proactiveinvestors.co.uk - February 22 at 9:19 AM
News IconProMetic Life Sciences Inc. (PFSCF: OTCQX International) - Satprnews - Satellite PR News (press release) (TSE:PLI)
www.satprnews.com - February 22 at 9:19 AM
News IconNarrowing in on Chart Levels for Prometic Life Sciences Inc (PLI.TO) - The Standard (TSE:PLI)
6milestandard.com - February 22 at 9:19 AM
News IconProMetic Life Sciences Inc PLI Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (TSE:PLI)
www.bioportfolio.com - February 20 at 9:28 AM
finance.yahoo.com logoIIROC Trading Halt - PLI (TSE:PLI)
finance.yahoo.com - February 18 at 10:13 AM
stockhouse.com logoProMetic Life Sciences Inc. T.PLI (TSE:PLI)
www.stockhouse.com - February 18 at 10:13 AM
News IconStock Focus: Watching the Levels for ProMetic Life Sciences Inc. (TSX:PLI) - Providence Standard (TSE:PLI)
providencestandard.com - February 17 at 5:58 PM
4-traders.com logoProMetic Life Sciences : IIROC Trading Halt - PLI (TSE:PLI)
www.4-traders.com - February 16 at 6:53 PM
finance.yahoo.com logoIIROC Trade Resumption - PLI (TSE:PLI)
finance.yahoo.com - February 16 at 6:53 PM
News IconExamining the Numbers on Shares of ProMetic Life Sciences Inc. (TSX:PLI) - Midway Monitor (TSE:PLI)
midwaymonitor.com - February 13 at 11:14 PM
News IconStock Survey: Checking Levels for ProMetic Life Sciences Inc. (TSX:PLI) - Baxter Review (TSE:PLI)
baxternewsreview.com - February 10 at 8:13 PM
News IconTechnicals in View on This Stock: ProMetic Life Sciences Inc. (TSX:PLI) - Davidson Register (TSE:PLI)
davidsonregister.com - February 10 at 2:33 AM
News IconTrend Update on ProMetic Life Sciences Inc. (PLI.TO) - Rives Journal (TSE:PLI)
rivesjournal.com - February 7 at 12:20 AM
News IconCanadian market dips on slumping energy stocks (TSE:PLI)
english.sina.com - February 6 at 7:20 PM
News IconProMetic Life Sciences just got less risky, says Echelon Wealth (TSE:PLI)
www.cantechletter.com - February 6 at 7:20 PM
News IconProMetic Life Sciences Inc. (PFSCF: OTCQX International) | California Capital Equity, LLC acquires 44 million ... - Satellite PR News (press release) (TSE:PLI)
www.satprnews.com - February 6 at 7:20 PM
nasdaq.com logoCANADA STOCKS-TSX slips as energy stocks fall, gold miners shine - Nasdaq (TSE:PLI)
www.nasdaq.com - February 6 at 7:20 PM
reuters.com logoBRIEF-ProMetic Life Sciences says California Capital Equity acquires 44 mln of co's shares (TSE:PLI)
www.reuters.com - February 6 at 9:08 AM
News IconLooking at the Technicals for ProMetic Life Sciences Inc. (PLI.TO) - Rives Journal (TSE:PLI)
rivesjournal.com - February 4 at 1:06 AM
News IconFocusing on the Numbers for ProMetic Life Sciences Inc. (PLI.TO) - Rives Journal (TSE:PLI)
rivesjournal.com - February 2 at 8:16 PM
News IconMarket Focus: Checking Indicators on Shares of ProMetic Life Sciences Inc. (PLI.TO) - Rives Journal (TSE:PLI)
rivesjournal.com - February 2 at 2:56 AM
News IconMeasuring the Levels on Shares of ProMetic Life Sciences Inc. (PLI ... - Rives Journal (TSE:PLI)
rivesjournal.com - February 1 at 1:29 AM
News IconWhat The Charts Are Saying About ProMetic Life Sciences Inc. (TSX:PLI) - Gilbert Daily (TSE:PLI)
gilbertdaily.com - January 31 at 8:29 PM
News IconFCF Score Review for ProMetic Life Sciences Inc. (TSX:PLI) - Gilbert Daily (TSE:PLI)
gilbertdaily.com - January 31 at 12:56 AM
News IconInside the Numbers: Looking at This Stock: ProMetic Life Sciences Inc. (PLI.TO) - Rives Journal (TSE:PLI)
rivesjournal.com - January 31 at 12:56 AM
capitalcube.com logoProMetic Life Sciences, Inc. breached its 50 day moving average in a Bullish Manner : PLI-CA : January 30, 2017 (TSE:PLI)
www.capitalcube.com - January 30 at 7:54 PM
News IconInside the Numbers: Looking at This Stock: ProMetic Life Sciences Inc. (PLI.TO) - Sherwood Daily (TSE:PLI)
sherwooddaily.com - January 30 at 12:43 AM
News IconF-Score Review on Shares of ProMetic Life Sciences Inc. (TSX:PLI) - Gilbert Daily (TSE:PLI)
gilbertdaily.com - January 28 at 5:42 AM
News IconKeeping Tabs on Technicals for ProMetic Life Sciences Inc. (PLI.TO) - Rives Journal (TSE:PLI)
rivesjournal.com - January 28 at 5:42 AM
News IconResearch Reports Initiated on Healthcare Stocks Oncolytics Biotech, ProMetic Life Sciences, Resverlogix, and Helius ... - Satellite PR News (press release) (TSE:PLI)
satprnews.com - January 27 at 6:00 AM
News IconVC Score In Focus for ProMetic Life Sciences Inc. (TSX:PLI) - Gilbert Daily (TSE:PLI)
gilbertdaily.com - January 27 at 6:00 AM
News IconAverage Directional Index in Review for ProMetic Life Sciences Inc. (PLI.TO) - Rives Journal (TSE:PLI)
rivesjournal.com - January 27 at 6:00 AM
4-traders.com logoProMetic Life Sciences : European Commission grants orphan drug designation to ProMetic's PBI-4050 drug for the treatment of Alstrom Syndrome (TSE:PLI)
www.4-traders.com - January 27 at 12:58 AM
News IconInvestors are Watching Technical Levels on Shares of ProMetic Life Sciences Inc. (PLI.TO) - Rives Journal (TSE:PLI)
rivesjournal.com - January 26 at 1:06 AM
News IconFollowing the Numbers on Shares of ProMetic Life Sciences Inc. (TSX:PLI) - Gilbert Daily (TSE:PLI)
gilbertdaily.com - January 26 at 1:06 AM
News IconTechnical Action Update on Shares of ProMetic Life Sciences Inc. (PLI.TO) - Rives Journal (TSE:PLI)
rivesjournal.com - January 24 at 8:00 PM
News IconInvestor Notebook: Taking a Look at Shares of ProMetic Life Sciences Inc. (TSX:PLI) - Gilbert Daily (TSE:PLI)
gilbertdaily.com - January 24 at 8:00 PM
News IconRelative Strength Index Review on Shares of ProMetic Life Sciences Inc. (PLI.TO) - Rives Journal (TSE:PLI)
rivesjournal.com - January 24 at 8:00 PM
finance.yahoo.com logoProMetic's PBI-4050 receives promising innovative medicine designation from the UK MHRA for the treatment of Alström Syndrome (TSE:PLI)
finance.yahoo.com - January 24 at 8:34 AM
finance.yahoo.com logo/R E P E A T -- ProMetic's PBI-4050 receives promising innovative medicine designation from the UK MHRA for the treatment of Alström Syndrome/ (TSE:PLI)
finance.yahoo.com - January 24 at 8:33 AM
News IconIndicators in Focus on ProMetic Life Sciences Inc. (TSX:PLI ... - Gilbert Daily (TSE:PLI)
gilbertdaily.com - January 23 at 7:35 PM
reuters.com logoPrometic Life Sciences Inc (PLI.TO) (TSE:PLI)
www.reuters.com - January 22 at 12:01 AM
News IconLooking at Moving Averages for ProMetic Life Sciences Inc. (PLI.TO) - Rives Journal (TSE:PLI)
rivesjournal.com - January 21 at 7:00 PM
News IconTrading Lines in Focus for ProMetic Life Sciences Inc. (PLI.TO) - Rives Journal (TSE:PLI)
rivesjournal.com - January 19 at 12:54 AM
4-traders.com logoProMetic Life Sciences : EUROPEAN COMMISSION GRANTS ORPHAN DRUG DESIGNATION TO PROMETIC’S PBI-4050 DRUG FOR THE TREATMENT OF ALSTRÖM SYNDROME (TSE:PLI)
www.4-traders.com - January 18 at 7:51 PM
finance.yahoo.com logoEuropean Commission grants orphan drug designation to ProMetic's PBI-4050 drug for the treatment of Alström Syndrome (TSE:PLI)
finance.yahoo.com - January 18 at 8:31 AM

Social

What is ProMetic Life Sciences' stock symbol?

ProMetic Life Sciences trades on the Tornton Stock Exchange (TSX) under the ticker symbol "PLI."

Where is ProMetic Life Sciences' stock going? Where will ProMetic Life Sciences' stock price be in 2017?

8 analysts have issued twelve-month price targets for ProMetic Life Sciences' stock. Their predictions range from C$3.30 to C$5.00. On average, they expect ProMetic Life Sciences' stock price to reach C$4.57 in the next year.

When will ProMetic Life Sciences announce their earnings?

ProMetic Life Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, March, 28th 2017.

How do I buy ProMetic Life Sciences stock?

Shares of ProMetic Life Sciences and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How much does a share of ProMetic Life Sciences stock cost?

One share of ProMetic Life Sciences stock can currently be purchased for approximately C$2.25.

ProMetic Life Sciences (TSE:PLI) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for ProMetic Life Sciences (TSE:PLI)

Earnings History Chart

Earnings by Quarter for ProMetic Life Sciences (TSE:PLI)

Dividend History Chart

Dividend Payments by Quarter for ProMetic Life Sciences (TSE:PLI)

Last Updated on 2/26/2017 by MarketBeat.com Staff